Transmucosal drug delivery devices offer diverse applications and uses in modern healthcare. These devices allow for non-invasive drug administration through mucous membranes, providing efficient and targeted delivery of medications. They are commonly used for delivering drugs to the bloodstream, bypassing the gastrointestinal tract and improving drug absorption. Transmucosal drug delivery devices feature precise dosing mechanisms, user-friendly designs, and the ability to administer a wide range of medications, making them valuable tools in managing various medical conditions and enhancing patient compliance and treatment outcomes.
According to Data Bridge Market Research, the Global Transmucosal Drug Delivery Devices Market is expected to reach USD 72.06 billion by 2029. The market is expected to grow with a CAGR of 6.20% in the forecast period of 2022 to 2029.
“Rising prevalence of chronic disorders boosts the market’s growth”
The rising prevalence of chronic disorders, such as diabetes, cardiovascular diseases, and cancer, is driving the growth of the transmucosal drug delivery devices market. Transmucosal drug delivery offers an effective and non-invasive method for delivering medications directly to the bloodstream through mucous membranes, improving drug absorption and patient compliance. These devices cater to the increasing demand for convenient and targeted drug delivery solutions, supporting patients in managing their chronic conditions more effectively and fueling the market's expansion.
What restraints the growth of the global transmucosal drug delivery devices market?
“High costs restraints the market’s growth”
The transmucosal drug delivery devices market faces constraints due to high costs associated with research, development, and production of these specialized devices. Additionally, the complex manufacturing processes and regulatory requirements contribute to increased expenses, limiting market accessibility and affordability. The higher costs may deter potential buyers and healthcare providers from adopting transmucosal drug delivery devices, thus hindering their widespread adoption and overall market growth. Efforts to optimize production and streamline regulatory processes are essential to overcome this obstacle and foster market expansion.
Segmentation: Global Transmucosal Drug Delivery Devices Market
The global transmucosal drug delivery devices market is segmented on the basis of type, indication, drug type, end user, and route of administration.
- On the basis of type, the transmucosal drug delivery devices market is segmented into passive transdermal drug delivery, and active transdermal drug delivery.
- On the basis of drug type, the transmucosal drug delivery devices market is fragmented into buccal tablets, oral sprays, sublingual films and wafers, gels, medicated confectionery, others.
- On the basis of indication, the transmucosal drug delivery devices market is bifurcated into pain management, addiction treatment, hormonal therapies, and others.
- On the basis of route of administration, the transmucosal drug delivery devices market is fragmented into buccal, nasal, vaginal, and urethral.
- On the basis of end user into hospitals, diagnostic centers, and others.
Regional Insights: North America dominates the Global Transmucosal Drug Delivery Devices Market
North America is estimated to dominate the transmucosal drug delivery devices market due to their increasing use in water treatment and pharmaceutical industries. Transmucosal drug delivery devices are utilized as essential components in water treatment processes and play a crucial role in pharmaceutical manufacturing, driving their demand and contributing to market growth in the region.
Asia-Pacific, on the other hand, will continue to however show lucrative growth within the forecast period due to high demand for transmucosal drug delivery devices is driven by various end-user industries in countries such as China, India, and other emerging economies. These industries, including agrochemicals, pharmaceuticals, and water treatment, rely heavily on transmucosal drug delivery devices for their diverse applications, propelling the growth of the market in these regions.
To know more about the study visit https://www.databridgemarketresearch.com/fr/reports/global-transmucosal-drug-delivery-devices-market
Recent Development
- In January 2021, Novartis AG completed the acquisition of Credence MedSystems, a move aimed at supporting the development and expansion of their drug delivery systems. With this partnership, Novartis AG gains access to Credence's advanced technology, which will enable them to enhance the delivery of their injectable medicines.
The Prominent Key Players Operating in the Global Transmucosal Drug Delivery Devices Market Include:
- Teva Pharmaceutical Industries Ltd. (Israel)
- Slan Medicinal Holdings LTD (Israel)
- MMB Healthcare, LLC (U.S.)
- BioDelivery Sciences International, Inc. (U.S.)
- Mylan N.V. (U.S.)
- Novartis AG (Switzerland)
- Bristol-Myers Squibb Company (U.S.)
- Bayer AG (Germany)
- Johnson & Johnson Private Limited (U.S.)
- Antares Pharma (U.S.)
- BD (U.S.)
- 3M (U.S.)
- Pfizer Inc. (U.S.)
- Boehringer Ingelheim International GmbH (Germany)
- Abbott (U.S.)
- Endo International plc (Ireland)
- Echo Pharmaceuticals B.V. (Netherlands)
- B. Braun Melsungen AG (Germany)
- Baxter (U.S.)
- GlaxoSmithKline plc (U.K.)
- Acrux Limited (Australia)
Above are the key players covered in the report, to know about more and exhaustive list of global transmucosal drug delivery devices market companies contact, https://www.databridgemarketresearch.com/fr/contact
Research Methodology: Global Transmucosal Drug Delivery Devices Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
